Quince Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
QNCX Nasdaq 8731 https://quincetx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Quince Therapeutics Inc

Quince Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - Sep 3rd, 2024 8:05 pm
Quince reports data from Phase III Ataxia-Telangiectasia treatment trial - Aug 16th, 2024 8:12 am
Quince Therapeutics Announces The Lancet Neurology Publication of Phase 3 ATTeST Clinical Trial Data Evaluating EryDex for the Treatment of Ataxia-Telangiectasia (A-T) - Aug 15th, 2024 11:00 am
Quince Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results - Aug 13th, 2024 8:05 pm
Quince Therapeutics doses first subject in Ataxia-Telangiectasia trial - Jun 26th, 2024 11:13 am
Quince Therapeutics Announces First Patient Dosed in Phase 3 Clinical Trial of EryDex for the Treatment of Ataxia-Telangiectasia - Jun 25th, 2024 11:00 am
FDA fast tracks Quince Therapeutics’ rare ataxia drug EryDex - Jun 4th, 2024 11:15 am
Quince Therapeutics Receives U.S. FDA Fast Track Designation for EryDex System - Jun 3rd, 2024 11:00 am
Quince Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results - May 13th, 2024 11:00 am
Quince Therapeutics to Present at The Citizens JMP Life Sciences Conference - May 6th, 2024 8:05 pm
Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results - Apr 1st, 2024 11:00 am
The Zacks Analyst Blog Highlights Quince Therapeutics and XBiotech - Mar 8th, 2024 9:40 am
Quince Therapeutics Launches Scientific Advisory Board - Feb 22nd, 2024 12:00 pm
Quince Therapeutics Appoints Former Reata Pharmaceuticals Chief R&D Officer Dr. Rajiv Patni to its Board of Directors - Feb 15th, 2024 12:00 pm
Quince Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference - Feb 7th, 2024 9:05 pm
Quince Therapeutics to Participate at Investor Events in January 2024 - Jan 4th, 2024 9:05 pm
10 Best Debt Free Penny Stocks To Buy Now - Dec 4th, 2023 12:21 pm
Quince Therapeutics Completes Acquisition of EryDel S.p.A. - Oct 23rd, 2023 11:00 am